Novelix Pharmaceuticals Ltd (NSE: NOVELIX), ISIN INE314I01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NOVELIX last traded at ₹69.00 (-3.46%), with a 52-week range of ₹38.00 to ₹92.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 51.98%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.